NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II

NCT02743416

UnknownN/A

Sponsor: Karolinska University Hospital

Conditions: Atrial Fibrillation, Stroke

Interventions: ECG screening (Zenicor-ECG) for atrial fibrillation

Countries: Sweden

STROKESTOP II will study if the biomarker NT-proBNP together with single-lead ECG can be used as a primary population screening tool for silent atrial fibrillation, and builds on previous results from the STROKESTOP study.

Eligibility overview

Sex: ALL

Age: 75 Years to 76 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Individuals born 1940 and 1941 residing in Stockholm at the time of inclusion

Exclusion Criteria:

* Not fulfilling the inclusion criteria

Locations (1)

Stockholm, Sweden